7Moss DJ, Schmidt C, Elliott S, et al. Strategies involved in developing an effective vaccine to EBV-associated diseases [J]. Adv Cancer Res. 1996.69:213-245.
8方峰．小儿病毒相关性疾病[M]．上海：第二军医大学出版社，2000.33-35．
二级参考文献15
1Kawa K.Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease.Int J Hematol,2003,78(1):24-31.
2Straathof KC,Bollard CM,Rooney CM,et al.Immunotherapy for Epstein-Barr virus-associated cancers in children.Oncologist,2003,8(1):83-98.
3Sayos J,Wu C,Morra M,et al.The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM.Nature,1998,395:462-469.
4Kasahara Y,Yachie A.Cell type specific infection of Epstein-Barr virus(EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.Crit Rev Oncol Hematol,2002,44(3):283-294.
5Taieb A,Plantin P,Du Pasquier P,et al.Gianotti-Crosti syndrome:a study of 26 cases.Br J Dermatol,1986,115(1):49-59.
7Kawa K.Epstein-Barr virus associated disease.Minophagen Med Rev,1999,44:1-13.
8Nakagawa A,Ito M,Saga S.Fatal cytotoxic T-cell proliferation in chronic active Epstein-Barr virus infection in childhood.Am J Clin Pathol,2002,117(2):283-290.
9Davi F,Delecluse HJ,Guiet P,et al.Burkitt-like lymphomas in AIDS patients:characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin' s lymphomas.Burkitt' s Lymphoma Study Group.J Clin Oncol,1998,16(12):3788-3795.
3Michihide Tokuhira,Atsushi Iizuka,Reiko Watanabe,Naoya Sekiguchi,Norihide Sato,Chen-Kang Chien,Yasunobu Sekiguchi,Tomoe Nemoto,Kyoko Hanzawa,Jun-ichi Tamaru,Shinji Itoyama,Hiroshi Suzuki,Tsutomu Takeuchi,Shigehisa Mori,Masahiro Kizaki.Severe degenerative change of multiple organs mediated by chronic active Epstein–Barr virus infection with infected T-cell expansion[J]. International Journal of Hematology . 2008 (5)
4Masao Hagihara,Takahide Tsuchiya,Osamu Hyodo,Yoko Ueda,Kei Tazume,Aya Masui,Ayako Kanemura,Fumiaki Yoshiba,Shinji Takashimizu,Shohei Matzusaki,Shunichi Kato,Tomomitsu Hotta.Clinical effects of infusing anti-epstein-barr virus (EBV)-specific cytotoxic T-lymphocytes into patients with severe chronic active EBV infection[J]. International Journal of Hematology . 2003 (1)
5Tsai MH,Hsu CY,Yen MH,et al.Epstein-Barr virus-associated infectious mononucleosis and risk factor analysis for complications in hospitalized children. Journal of Microbiology Immunology and Infection . 2005
6Bell A T,Fortune B,Sheeler R.Clinical inquiries. What test in the best for diagnosing infectious mononucleosis. Journal of Family Practice . 2006
7Hurt C,Tammaro D.Diagnostic evaluation of mononucleosis-like illnesses. The American Journal of Medicine . 2007
8Straus SE.The chronic mononucleosis syndrome. The Journal of Infectious Diseases . 1988
9M Okano,K Kawa,H Kimura,A Yachie,H Wakiguchi,A Maeda,S Imai,S Ohga,H Kanegane,S Tsuchiya,T Morio,M Mori,S Yokota,S Imashuku.Proposed guidelines for diagnosing chronic active Epstein–Barr virus infection. American Journal of Hematology . 2005
10Kimura H,Hoshino Y,Hara S,et al.Differences between T cell-type;and natural killer cell-type chronic active Apstein-Barr virus infection. The Journal of Infectious Diseases . 2005
